DARIOHEALTH CORP (DRIO) Stock Overview
USA - NASDAQ:DRIO - US23725P3082 - Common Stock
DRIO Key Statistics, Chart & Performance
The current stock price of DRIO is 16.37 USD. In the past month the price increased by 114.27%. In the past year, price decreased by -19.75%.
DRIO Latest News, Press Relases and Analysis
DRIO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 40.51 | 49.47B | ||
| DOCS | DOXIMITY INC-CLASS A | 49.35 | 13.77B | ||
| WAY | WAYSTAR HOLDING CORP | 34.74 | 6.72B | ||
| HTFL | HEARTFLOW INC | N/A | 2.98B | ||
| CERT | CERTARA INC | 26.53 | 2.09B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.61B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 12.54 | 1.53B | ||
| SDGR | SCHRODINGER INC | N/A | 1.53B | ||
| PHR | PHREESIA INC | N/A | 1.39B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| EVH | EVOLENT HEALTH INC - A | N/A | 945.96M | ||
| CTEV | CLARITEV CORP | N/A | 944.72M |
Related stock screener links
About DRIO
Company Profile
DarioHealth Corp is a US-based company operating in Health Care Technology industry. The company is headquartered in New York City, New York and currently employs 196 full-time employees. The company went IPO on 2013-03-08. DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Company Info
DARIOHEALTH CORP
322 W 57Th St. #33B
New York City NEW YORK 10019 US
CEO: Erez Raphael
Employees: 199
Phone: 16466654667
DARIOHEALTH CORP / DRIO FAQ
What is the stock price of DARIOHEALTH CORP today?
The current stock price of DRIO is 16.37 USD. The price increased by 5.27% in the last trading session.
What is the ticker symbol for DARIOHEALTH CORP stock?
The exchange symbol of DARIOHEALTH CORP is DRIO and it is listed on the Nasdaq exchange.
On which exchange is DRIO stock listed?
DRIO stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for DARIOHEALTH CORP stock?
10 analysts have analysed DRIO and the average price target is 22.7 USD. This implies a price increase of 38.64% is expected in the next year compared to the current price of 16.37. Check the DARIOHEALTH CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DARIOHEALTH CORP worth?
DARIOHEALTH CORP (DRIO) has a market capitalization of 58.11M USD. This makes DRIO a Micro Cap stock.
How many employees does DARIOHEALTH CORP have?
DARIOHEALTH CORP (DRIO) currently has 199 employees.
What are the support and resistance levels for DARIOHEALTH CORP (DRIO) stock?
DARIOHEALTH CORP (DRIO) has a support level at 15.55 and a resistance level at 16.38. Check the full technical report for a detailed analysis of DRIO support and resistance levels.
Is DARIOHEALTH CORP (DRIO) expected to grow?
The Revenue of DARIOHEALTH CORP (DRIO) is expected to decline by -10.78% in the next year. Check the estimates tab for more information on the DRIO EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DARIOHEALTH CORP (DRIO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DRIO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DRIO, evaluating the profitability, health, valuation and growth aspects
- DARIOHEALTH CORP (DRIO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DARIOHEALTH CORP (DRIO) Sales and EPS estimates to see what analysts future expectations are.
- DARIOHEALTH CORP (DRIO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DARIOHEALTH CORP (DRIO) Insider and Institutional Ownership to learn about the owners and their transactions.
- DARIOHEALTH CORP (DRIO) Stock Chart to make your own analysis
- DARIOHEALTH CORP (DRIO) Latest news and press-releases to stay up to date.
Does DARIOHEALTH CORP (DRIO) stock pay dividends?
DRIO does not pay a dividend.
When does DARIOHEALTH CORP (DRIO) report earnings?
DARIOHEALTH CORP (DRIO) will report earnings on 2025-11-05, before the market open.
What is the Price/Earnings (PE) ratio of DARIOHEALTH CORP (DRIO)?
DARIOHEALTH CORP (DRIO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-13.2).
DRIO Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to DRIO. When comparing the yearly performance of all stocks, DRIO is a bad performer in the overall market: 72.43% of all stocks are doing better.
DRIO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to DRIO. The financial health of DRIO is average, but there are quite some concerns on its profitability.
DRIO Financial Highlights
Over the last trailing twelve months DRIO reported a non-GAAP Earnings per Share(EPS) of -13.2. The EPS decreased by -373.12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -39.18% | ||
| ROE | -66.33% | ||
| Debt/Equity | 0.48 |
DRIO Forecast & Estimates
10 analysts have analysed DRIO and the average price target is 22.7 USD. This implies a price increase of 38.64% is expected in the next year compared to the current price of 16.37.
For the next year, analysts expect an EPS growth of -144.33% and a revenue growth -10.78% for DRIO